NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / World News / Coronavirus: Could this drug be the treatment we're looking for?
    Next Article
    Coronavirus: Could this drug be the treatment we're looking for?

    Coronavirus: Could this drug be the treatment we're looking for?

    By Siddhant Pandey
    Jul 23, 2020
    07:47 pm

    What's the story

    As the coronavirus outbreak continues to spread across the world, the search for a treatment or cure remains on.

    Trials of one experimental drug now suggest that a possible new treatment could significantly reduce the number of patients needing intensive care.

    The treatment is based on a protein called Interferon Beta, which the body produces naturally in response to viral infections.

    Trial

    Trial involved 101 participants from 9 UK hospitals

    The drug, called SNG001, has been produced by the Southampton-based biotech firm Synairgen.

    Synairgen is a spin-out company from the University of Southampton.

    University Hospital Southampton was the lead center for the double-blind trial, which involved 101 participants admitted at nine United Kingdom hospitals.

    Half of the participants were administered the treatment, while the other half was administered the placebo.

    Results

    Drug resulted in 79% lower risk of developing severe disease

    On Monday, Synairgen announced that the patients who received SNG001 had a 79% lower risk of developing severe disease compared to placebo.

    Those who received SNG001 were more than twice as likely to recover from COVID-19 as those on placebo. The drug significantly reduced breathlessness in patients.

    Further, three participants in the placebo group died while no fatalities were reported among those receiving SNG001.

    Quote

    Initial results are very positive: Trial's chief investigator

    Tom Wilkinson, a professor of respiratory medicine at the University of Southampton and the trial's chief investigator, told The Guardian, "The initial results are very positive and provide a strong platform to take this drug forward in clinical development, working closely with an international regulatory framework to try and get this drug into patient care as soon as is possible."

    Issues

    Trial too small, say experts

    Since the results were shared, experts have cautioned that the trial is too small.

    Dr. Charlotte Summers—an intensive care specialist at Addenbrooke's Hospital, University of Cambridge—highlighted that the trial results also did not reveal the number of people who required mechanical ventilation.

    However, Dr. Summers restrained from jumping to conclusions until the full research dataset is published and expressed faith in the NIHR.

    Outbreak

    Over 15 million infected with coronavirus worldwide

    Globally, the coronavirus has afflicted over 15 million (1.5 crore) and led to the deaths of 6.23 lakh people, according to the Johns Hopkins University tracker.

    At 12,38,635 cases, India has reported the world's third-highest number of infections after the United States (3.9 million) and Brazil (2.2 million).

    India's total cases include 4,26,167 active infections while the death toll in the outbreak is 29,861.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    United Kingdom
    United States of America
    University of Cambridge
    Coronavirus

    Latest

    Meet Nurabot, Foxconn's AI robot nurse already treating patients NVIDIA
    'No booze, no cigarettes': Chinese officials told to cut costs Xi Jinping
    Conan O'Brien joins 'Toy Story 5' as a new character Hollywood
    All we know about Nancy Tyagi-Neha Bhasin's Cannes outfit controversy  Cannes Film Festival

    United Kingdom

    Twitter is busy debating 'How do you draw letter X?' X
    UK: Dozens of girls subjected to breast ironing. But why? United Nations (UN)
    US, UK, France move UN Security Council to blacklist Masood Pulwama
    Here's a look at Reliance Jio's unlimited international roaming plans India

    United States of America

    Why DuckDuckGo is not working in India? India
    Britain to ease quarantine rules for travelers from 50+ countries Europe
    Donald Trump Jr.'s girlfriend tests positive for COVID-19 Donald Trump
    India's Mangalyaan just photographed Mars' mysterious moon 'Phobos' Mangalyaan

    University of Cambridge

    Knighthood for Indian-origin professor Shankar Balasubramanian Kolkata
    Artificial Womb 'Biobag' for preemies: Are human babies next? Health & Wellness
    UK to fund solar energy, health projects in India India
    Stephen Hawking's 1966 PhD thesis posted online, breaks the internet! Physics

    Coronavirus

    Bill Gates warns COVID-19 could turn into 'deadlier pandemic' Microsoft
    Russian University successfully finishes trials of world's first COVID-19 vaccine Russia News
    CBSE declares results for Class 12: Check yours here Central Board of Secondary Education (CBSE)
    Coronavirus: India's death rate is declining, positivity rate surging India
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025